These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24328365)

  • 21. Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs).
    Strachan JP; Kombo DC; Mazurov A; Heemstra R; Bhatti BS; Akireddy R; Murthy S; Miao L; Jett JE; Speake J; Bencherif M
    Eur J Med Chem; 2014 Oct; 86():60-74. PubMed ID: 25147147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors.
    Batista VS; Gonçalves AM; Nascimento-Júnior NM
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
    J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200.
    Mallipeddi PL; Pedersen SE; Briggs JM
    J Mol Graph Model; 2013 Jul; 44():145-54. PubMed ID: 23831994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.
    Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Arunrungvichian K; Chongruchiroj S; Sarasamkan J; Schüürmann G; Brust P; Vajragupta O
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening.
    Dey R; Chen L
    J Biomol Struct Dyn; 2011 Apr; 28(5):695-715. PubMed ID: 21294583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of noncompetitive inhibitors with the alpha3beta2 nicotinic acetylcholine receptor investigated by affinity chromatography and molecular docking.
    Jozwiak K; Ravichandran S; Collins JR; Moaddel R; Wainer IW
    J Med Chem; 2007 Nov; 50(24):6279-83. PubMed ID: 17973360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the binding energy profiles of full agonists, partial agonists, and antagonists of the α7 nicotinic acetylcholine receptor.
    Tabassum N; Ma Q; Wu G; Jiang T; Yu R
    J Mol Model; 2017 Sep; 23(9):251. PubMed ID: 28770361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Lee KW
    Eur J Med Chem; 2011 Jul; 46(7):2937-47. PubMed ID: 21531051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors.
    Mordvitsev DY; Polyak YL; Kuzmin DA; Levtsova OV; Tourleigh YV; Utkin YN; Shaitan KV; Tsetlin VI
    Comput Biol Chem; 2007 Apr; 31(2):72-81. PubMed ID: 17392029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural model for the binding sites of allosterically potentiating ligands on nicotinic acetylcholine receptors.
    Luttmann E; Ludwig J; Höffle-Maas A; Samochocki M; Maelicke A; Fels G
    ChemMedChem; 2009 Nov; 4(11):1874-82. PubMed ID: 19739198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential modulating effect of the Ascaris suum nicotinic acetylcholine receptor (nAChR) by compounds GSK575594A, diazepam and flumazenil discovered by structure-based virtual screening approach.
    Stevanovic S; Marjanović DS; Trailović SM; Zdravković N; Perdih A; Nikolic K
    Mol Biochem Parasitol; 2021 Mar; 242():111350. PubMed ID: 33422580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
    Ahmadi M; Nowroozi A; Shahlaei M
    J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptor.
    Jozwiak K; Targowska-Duda KM; Kaczor AA; Kozak J; Ligeza A; Szacon E; Wrobel TM; Budzynska B; Biala G; Fornal E; Poso A; Wainer IW; Matosiuk D
    Bioorg Med Chem; 2014 Dec; 22(24):6846-56. PubMed ID: 25464883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies.
    Tuccinardi T; Poli G; Romboli V; Giordano A; Martinelli A
    J Chem Inf Model; 2014 Oct; 54(10):2980-6. PubMed ID: 25211541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes.
    Ellison M; Gao F; Wang HL; Sine SM; McIntosh JM; Olivera BM
    Biochemistry; 2004 Dec; 43(51):16019-26. PubMed ID: 15609996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
    Kurczab R; Bojarski AJ
    J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.